125 related articles for article (PubMed ID: 6518973)
1. In vitro transfer of six benzamides in the human placenta.
Nandakumaran M; Challier JC; Rey E; Richard MO; Olive G
Dev Pharmacol Ther; 1984; 7 Suppl 1():60-6. PubMed ID: 6518973
[No Abstract] [Full Text] [Related]
2. The effects of substituted benzamides on frog rectus abdominis.
Fontaine J; Reuse J
Eur J Pharmacol; 1980 Nov; 68(1):55-60. PubMed ID: 6969659
[TBL] [Abstract][Full Text] [Related]
3. Effect of substituted benzamides on prolactin secretion in the rat.
Kakigi T; Maeda K; Tanimoto K; Kaneda H; Shintani T
Biol Psychiatry; 1992 Apr; 31(8):827-31. PubMed ID: 1353691
[No Abstract] [Full Text] [Related]
4. [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].
Müller-Vahl KR
Nervenarzt; 2007 Mar; 78(3):264, 266-8, 270-1. PubMed ID: 16924461
[TBL] [Abstract][Full Text] [Related]
5. Tiapride binds to mouse striatal tissue pre-exposed to dopamine stimulation.
Fortune DH; Costall B; Naylor RJ
J Pharm Pharmacol; 1980 Jul; 32(7):514-7. PubMed ID: 6105195
[No Abstract] [Full Text] [Related]
6. [Neurotropic anisamides (author's transl)].
Ropert R; Caillard F; Petitjean F
Sem Hop; 1979 Nov 18-25; 55(39-40):1858-65. PubMed ID: 44766
[TBL] [Abstract][Full Text] [Related]
7. [Four benzamides (metoclopramide, sulpiride, sultopride and tiapride) effects on the oestrus cycle of the female rat: a comparative statistical study (author's transl)].
Bruguerolle B; Jadot G; Valli M; Bouyard L; Fabregou-Bergier P; Perrot J; Bouyard P
J Pharmacol; 1981; 12(1):27-36. PubMed ID: 7194403
[TBL] [Abstract][Full Text] [Related]
8. (-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.
Castelli MP; Mocci I; Sanna AM; Gessa GL; Pani L
Eur J Pharmacol; 2001 Dec; 432(2-3):143-7. PubMed ID: 11740949
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of tiapride in patients with tardive dyskinesia and Huntington's disease.
Roos RA; de Haas EJ; Buruma OJ; de Wolff FA
Eur J Clin Pharmacol; 1986; 31(2):191-4. PubMed ID: 2948825
[TBL] [Abstract][Full Text] [Related]
10. Determination of sultopride and tiapride in serum by gas chromatography using a surface ionisation detector.
Kamizono A; Inotsume N; Miyamoto K; Ueda K; Miyakawa T; Arimoto H; Nakano M
J Chromatogr; 1991 Jun; 567(1):113-20. PubMed ID: 1918238
[TBL] [Abstract][Full Text] [Related]
11. [Interactions of 5 benzamides with ethanol on various psychopharmacology tests].
Bourin M; Colombel MC; Larousse C
Pathol Biol (Paris); 1985 Mar; 33(3):183-8. PubMed ID: 3892445
[TBL] [Abstract][Full Text] [Related]
12. The substituted benzamides--a novel class of dopamine antagonists.
Jenner P; Marsden CD
Life Sci; 1979 Aug; 25(6):479-85. PubMed ID: 40086
[No Abstract] [Full Text] [Related]
13. Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's disease.
Seeman P
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1096. PubMed ID: 25256309
[No Abstract] [Full Text] [Related]
14. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
[TBL] [Abstract][Full Text] [Related]
15. 3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs.
Csernansky JG; Csernansky CA; Hollister LE
Experientia; 1985 Nov; 41(11):1419-21. PubMed ID: 4065296
[TBL] [Abstract][Full Text] [Related]
16. Tiapride in 12 Huntington's disease patients.
Quinn N; Marsden CD
J Neurol Neurosurg Psychiatry; 1985 Mar; 48(3):292. PubMed ID: 3156967
[No Abstract] [Full Text] [Related]
17. Effects of repeated tiapride administration on anterior pituitary dopamine receptors and prolactin release in the rat.
Apud JA; Masotto C; Monopoli A; Ongini E; Rovescalli AC; Racagni G
Pharmacol Res Commun; 1987 Feb; 19(2):119-29. PubMed ID: 3588649
[TBL] [Abstract][Full Text] [Related]
18. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
Meisenzahl EM; Schmitt G; Gründer G; Dresel S; Frodl T; la Fougère C; Scheuerecker J; Schwarz M; Boerner R; Stauss J; Hahn K; Möller HJ
Pharmacopsychiatry; 2008 Sep; 41(5):169-75. PubMed ID: 18763218
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice.
Donahue TJ; Hillhouse TM; Webster KA; Young R; De Oliveira EO; Porter JH
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3507-3520. PubMed ID: 28921163
[TBL] [Abstract][Full Text] [Related]
20. Consensus on the use of substituted benzamides in psychiatric patients.
Racagni G; Canonico PL; Ravizza L; Pani L; Amore M
Neuropsychobiology; 2004; 50(2):134-43. PubMed ID: 15292667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
